LATEST

• BUSINESS Towa Pins NO2 as Key Driver of Nitrosation, Eyes Lower Filter Costs
  July 22, 2026

• REGULATORY Japan Backs Calquence-Venclexta Regimen for Untreated CLL via Label Updates
  July 22, 2026

• BUSINESS FRONTEO Taps Bayer Ex-Chair Eiki as Advisor
  July 22, 2026

• BUSINESS JCR Grabs 1st Overseas Nod for Izcargo in UAE
  July 22, 2026

• BUSINESS Carna Bio’s AML Drug Candidate Earns US Orphan Tag
  July 22, 2026

• BUSINESS Takara Bio to Transfer Cell Processing CDMO Biz to S-RACMO
  July 22, 2026

• BUSINESS Takara Bio Voluntary Buyout Draws 148 Employees
  July 22, 2026

• REGULATORY Japan OKs Honebuto, Growth Strategy with Patented Drug Market Goals
  July 21, 2026

• BUSINESS Rhythm Pharma Gears Up for First Japan Launch with 50-Strong Team
  July 21, 2026

• REGULATORY Takeda’s Oveporexton, Rhythm’s Imcivree Up for Japan Panel Review Aug. 3
  July 21, 2026

• REGULATORY Japan’s Immunization Act Bill Set to Clear Diet after Session Extension
  July 21, 2026

• ORGANIZATION JPMA Backs Honebuto 2026 Innovation Agenda
  July 21, 2026

• BUSINESS Fujifilm Toyama Chemical Forms 1st Product-Dedicated Unit for Savyscus
  July 21, 2026

• BUSINESS Meiji’s Hiyasta Earns Approval in Thailand
  July 21, 2026

• BUSINESS US FDA Accepts Shionogi’s Pediatric Fetroja Filing
  July 21, 2026

• BUSINESS Kaken’s Vascular Malformation Drug Shows Efficacy in Japan PIII
  July 21, 2026

• REGULATORY Japan Eyes Early FY2027 Rollout of RSV Antibodies under NIP: Minister
  July 21, 2026

• BUSINESS J&J’s Carvykti Wins Japan Approval for Earlier-Line MM Use
  July 21, 2026

• ORGANIZATION JPMA, PhRMA Raise Alarm over Generic Approvals During Patent Extensions
  July 17, 2026

• BUSINESS Merck Biopharma Starts Japan PIII Trial of LH/FSH Combo
  July 17, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• …
• Next ›
• 最終 »